https://kansasscitechreporter.com/article/906800541-revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer Kansas Sci-Tech Reporter en PressRelease 2026-04-19T18:00:00+00:00 Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://kansasscitechreporter.com/article/906732361-cregis-shines-at-paris-blockchain-week-2026-accelerating-european-expansion Kansas Sci-Tech Reporter en PressRelease 2026-04-19T09:45:18+00:00 Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion https://ml.globenewswire.com/media/5bebd304-3269-4385-9874-50701ff2353a/medium/cover-image.jpeg https://kansasscitechreporter.com/article/906711088-challenge-accepted-schneider-electric-helps-industry-turn-toughest-problems-into-competitive-advantage Kansas Sci-Tech Reporter en PressRelease 2026-04-19T07:00:00+00:00 Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage https://ml.globenewswire.com/media/f9f1757e-4ed3-4fe7-939b-35cd2b1f43e1/medium/schneider-electric.jpg https://kansasscitechreporter.com/article/906674833-direct-meds-glp-1-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying Kansas Sci-Tech Reporter en PressRelease 2026-04-19T03:39:34+00:00 Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying https://ml.globenewswire.com/media/065e49c6-04a6-4223-a1ee-caea644c6a7f/medium/direct-meds.PNG https://kansasscitechreporter.com/article/906674828-strovemont-capital-claims-evaluated-is-strovemont-capital-trading-platform-legit-hidden-features-trust-facts-real-user-results Kansas Sci-Tech Reporter en PressRelease 2026-04-19T03:10:24+00:00 Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results https://ml.globenewswire.com/media/6c80b7b0-a3e5-46d9-a0a2-28f7c0c723bc/medium/strovemont-capital.png https://kansasscitechreporter.com/article/906659883-bramridge-trust-unveiled-should-you-join-bramridge-trust-features-performance-fees-real-user-insights Kansas Sci-Tech Reporter en PressRelease 2026-04-19T02:30:20+00:00 Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights! https://ml.globenewswire.com/media/298d2649-26e8-49ac-ab07-531c079947cf/medium/bramridge-trust.PNG https://kansasscitechreporter.com/article/906622428-crypto-news-alphapepe-ai-dex-demo-over-1000-users-whilst-xrp-price-prediction-targets-5-00-following-official-sec-commodity-status Kansas Sci-Tech Reporter en PressRelease 2026-04-18T22:45:00+00:00 Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status https://ml.globenewswire.com/media/bb8173de-d338-4af5-9802-2bcdb498429b/medium/alphapepe.jpg https://kansasscitechreporter.com/article/906577634-pliant-therapeutics-announces-presentation-of-updated-data-from-the-phase-1-trial-of-pln-101095-in-patients-with-ici-refractory-solid-tumors-at-the Kansas Sci-Tech Reporter en PressRelease 2026-04-18T17:31:00+00:00 Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/e31d4c37-738e-4662-861d-675c8c564317/medium/figure-1.jpg https://kansasscitechreporter.com/article/906577667-ring-a-ding-launches-openclaw-skill-for-ai-agent-phone-calls Kansas Sci-Tech Reporter en PressRelease 2026-04-18T17:18:25+00:00 Ring-a-Ding Launches OpenClaw Skill for AI Agent Phone Calls https://ml.globenewswire.com/Resource/Download/d39b62af-4928-42e0-a75f-20e6a819ac8a/screenshot-2026-04-15-at-14-00-39.png https://kansasscitechreporter.com/article/906577555-theriva-biologics-anuncia-la-pr-xima-presentaci-n-de-datos-adicionales-del-ensayo-cl-nico-virage-de-fase-2b-del-vcn-01-para-el-c-ncer-de-p-ncreas Kansas Sci-Tech Reporter en PressRelease 2026-04-18T17:17:08+00:00 Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026 https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://kansasscitechreporter.com/article/906525665-other-world-computing-owc-launches-macdrive-12-at-nab-2026-one-solution-for-complete-mac-disk-access-on-windows-including-native-encrypted-apfs Kansas Sci-Tech Reporter en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows - Including Native Encrypted APFS Support https://ml.globenewswire.com/media/543d94b6-063b-4931-b524-f7b75a9d230c/medium/owc-macdrive-12-application-window-screenshot.png https://kansasscitechreporter.com/article/906525713-other-world-computing-launches-owc-express-4m2-ultra-at-nab-2026-thunderbolt-5-four-slot-nvme-m-2-ssd-enclosure Kansas Sci-Tech Reporter en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure https://ml.globenewswire.com/media/d50919d2-169d-4edd-8afc-6ca3693ad99d/medium/owc-4m2-ultra-front.png https://kansasscitechreporter.com/article/906526269-tradull-develops-structured-framework-to-improve-visibility-in-commodity-trade-processes Kansas Sci-Tech Reporter en PressRelease 2026-04-18T11:36:23+00:00 Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes https://ml.globenewswire.com/media/e0fbd3ef-5565-4bc7-a9c9-d9d1acca96a6/medium/tradull.jpg https://kansasscitechreporter.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study Kansas Sci-Tech Reporter en PressRelease 2026-04-18T10:00:00+00:00 Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://kansasscitechreporter.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude Kansas Sci-Tech Reporter en PressRelease 2026-04-18T10:00:00+00:00 Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://kansasscitechreporter.com/article/906476329-crypto-news-alphapepe-announces-880k-raised-while-ethereum-price-prediction-targets-4-000-on-heavy-whale-accumulation Kansas Sci-Tech Reporter en PressRelease 2026-04-18T07:00:00+00:00 Crypto News: AlphaPepe Announces $880k Raised While Ethereum Price Prediction Targets $4,000 on Heavy Whale Accumulation https://ml.globenewswire.com/media/64727b55-920f-41c6-8367-978501174859/medium/alphapepe.jpg https://kansasscitechreporter.com/article/906451168-argenx-brings-neuromuscular-leadership-to-aan-2026-with-new-data-supporting-broader-vyvgart-use-across-mg-and-cidp Kansas Sci-Tech Reporter en PressRelease 2026-04-18T05:00:00+00:00 argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://kansasscitechreporter.com/article/906400487-redcloud-holdings-plc-receives-notice-regarding-minimum-bid-price-requirement Kansas Sci-Tech Reporter en PressRelease 2026-04-18T00:15:00+00:00 RedCloud Holdings Plc Receives Notice Regarding Minimum Bid Price Requirement https://ml.globenewswire.com/media/5c1cfb28-9945-43bb-a5bc-7789676cae2f/small/2023-redcloud-product-logos-13-e1691517467929-png.png https://kansasscitechreporter.com/article/906400275-crypto-news-alphapepe-announces-870k-raised-amid-dogecoin-price-prediction-targeting-0-47-following-x-money-beta-launch Kansas Sci-Tech Reporter en PressRelease 2026-04-17T22:30:00+00:00 Crypto News: AlphaPepe Announces $870k Raised Amid Dogecoin Price Prediction Targeting $0.47 Following X Money Beta Launch https://ml.globenewswire.com/media/01407950-d491-485a-8f91-08f42dedec11/medium/alphapepe.jpg https://kansasscitechreporter.com/article/906378380-fyresite-reaches-new-heights-with-shopify-premier-partner-promotion Kansas Sci-Tech Reporter en PressRelease 2026-04-17T21:58:00+00:00 Fyresite Reaches New Heights With Shopify Premier Partner Promotion https://pressranger.s3.us-west-1.amazonaws.com/3232398/jason-sean.jpg https://kansasscitechreporter.com/article/906378249-rocket-doctor-amends-45-degree-agreement Kansas Sci-Tech Reporter en PressRelease 2026-04-17T21:18:34+00:00 Rocket Doctor Amends 45 Degree Agreement https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png https://kansasscitechreporter.com/article/906376671-iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Kansas Sci-Tech Reporter en PressRelease 2026-04-17T21:15:00+00:00 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg https://kansasscitechreporter.com/article/906378336-boundless-bio-presents-preclinical-breast-cancer-data-from-its-oral-kinesin-degrader-program-at-2026-aacr-annual-meeting Kansas Sci-Tech Reporter en PressRelease 2026-04-17T20:49:47+00:00 Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://kansasscitechreporter.com/article/906376058-celularity-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing Kansas Sci-Tech Reporter en PressRelease 2026-04-17T20:35:00+00:00 Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing https://ml.globenewswire.com/media/ODBmYzBlZTctZGRjMC00YzIzLWEyYTEtODVjOGVkNjJlM2M4LTEyMTY1NjItMjAyNi0wNC0xNy1lbg==/tiny/Celularity-Inc-.png https://kansasscitechreporter.com/article/906376026-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Kansas Sci-Tech Reporter en PressRelease 2026-04-17T20:15:00+00:00 Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://kansasscitechreporter.com/article/906377393-bgin-blockchain-limited-schedules-the-fiscal-year-2025-earnings-and-conference-call-on-april-24-2026 Kansas Sci-Tech Reporter en PressRelease 2026-04-17T20:15:00+00:00 BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026 https://ml.globenewswire.com/media/ZGIzMjlmYjItNmZjNy00YzI0LWJkZjYtM2Q4YTg3OWRkMWMwLTEzMDQ3MDEtMjAyNi0wNC0xNy1lbg==/tiny/BGIN-Blockchain-Limited.png https://kansasscitechreporter.com/article/906378008-ttec-schedules-first-quarter-2026-earnings-release-and-webcast-of-investor-conference-call Kansas Sci-Tech Reporter en PressRelease 2026-04-17T20:10:00+00:00 TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call https://ml.globenewswire.com/media/8488146d-993c-40c8-8d4c-b993aa023cb2/small/screenshot-2025-10-17-132937-png.png